See more : Sumeet Industries Limited (SUMEETINDS.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Taiyen Biotech Co., Ltd. (1737.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Taiyen Biotech Co., Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Asahi Intelligence Service Co., Ltd. (9799.T) Income Statement Analysis – Financial Results
- Tsinghua Tongfang Co.,Ltd. (600100.SS) Income Statement Analysis – Financial Results
- Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) Income Statement Analysis – Financial Results
- Nykredit Invest Korte Obligationer KL (NYIKO.CO) Income Statement Analysis – Financial Results
- Manomay Tex India Limited (MANOMAY.BO) Income Statement Analysis – Financial Results
Taiyen Biotech Co., Ltd. (1737.TW)
About Taiyen Biotech Co., Ltd.
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. Its products portfolio includes various salt and seawater chemical products; bath salt, bath salt milk, salt soap, algae soap, and shampoo; beverage and drinking water; toothpaste, salt mouthwash, and contact lenses maintenance liquid; salt for washing vegetables, fruits, and other products; and food and food additives. The company also manufactures pharmaceuticals, including cosmetics and environmental medicines. In addition, it imports and exports daily necessities and cosmetic products. Further, the company is involved in the supply, introduction, and management consulting of industrial salt technology. Taiyen Biotech Co., Ltd. was founded in 1952 and is based in Tainan, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.41B | 3.61B | 4.10B | 3.13B | 2.91B | 3.00B | 2.76B | 2.76B | 2.76B | 2.60B | 2.41B | 2.30B | 2.30B | 2.15B | 1.98B |
| Cost of Revenue | 2.20B | 2.34B | 2.72B | 1.82B | 1.70B | 1.80B | 1.62B | 1.61B | 1.72B | 1.68B | 1.58B | 1.52B | 1.32B | 1.21B | 1.21B |
| Gross Profit | 1.21B | 1.28B | 1.37B | 1.31B | 1.21B | 1.20B | 1.14B | 1.15B | 1.04B | 916.79M | 826.98M | 772.60M | 978.32M | 944.88M | 773.84M |
| Gross Profit Ratio | 35.49% | 35.33% | 33.53% | 41.77% | 41.64% | 40.02% | 41.31% | 41.70% | 37.75% | 35.30% | 34.33% | 33.65% | 42.57% | 43.89% | 39.08% |
| Research & Development | 60.50M | 60.64M | 57.60M | 73.98M | 68.62M | 58.47M | 57.47M | 53.66M | 54.11M | 56.71M | 64.88M | 60.73M | 61.73M | 56.51M | 40.69M |
| General & Administrative | 212.49M | 217.23M | 217.99M | 212.18M | 200.29M | 215.83M | 188.53M | 174.48M | 174.54M | 155.60M | 152.71M | 157.04M | 153.61M | 154.19M | 155.25M |
| Selling & Marketing | 589.50M | 553.68M | 568.47M | 558.11M | 521.65M | 508.28M | 474.77M | 510.88M | 504.36M | 539.52M | 506.70M | 506.89M | 532.92M | 504.80M | 351.74M |
| SG&A | 836.56M | 770.92M | 786.46M | 770.29M | 721.94M | 724.11M | 663.30M | 685.36M | 678.90M | 695.12M | 659.41M | 663.93M | 686.53M | 659.00M | 506.99M |
| Other Expenses | 0.00 | 90.06M | -13.32M | 4.88M | 12.94M | 114.86M | 8.38M | 8.43M | 12.86M | 80.80M | 47.81M | -5.01M | 4.16M | -6.92M | -31.78M |
| Operating Expenses | 897.05M | 831.56M | 844.06M | 844.27M | 790.56M | 782.57M | 720.77M | 739.02M | 733.01M | 751.83M | 727.69M | 724.66M | 748.26M | 715.50M | 547.67M |
| Cost & Expenses | 3.10B | 3.17B | 3.57B | 2.67B | 2.49B | 2.58B | 2.34B | 2.35B | 2.45B | 2.43B | 2.31B | 2.25B | 2.07B | 1.92B | 1.75B |
| Interest Income | 0.00 | 17.88M | 10.66M | 15.19M | 22.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.71M | 12.59M | 6.23M | 5.02M |
| Interest Expense | 3.35M | 4.52M | 5.94M | 3.61M | 2.40M | 3.00K | 3.00K | 3.00K | 4.00K | 8.00K | 3.57M | 3.67M | 3.21M | 3.12M | 2.69M |
| Depreciation & Amortization | 198.06M | 182.45M | 190.51M | 173.79M | 159.25M | 158.58M | 148.59M | 153.32M | 158.87M | 138.84M | 132.13M | 125.51M | 115.11M | 112.21M | 115.91M |
| EBITDA | 518.27M | 717.56M | 706.37M | 641.99M | 591.95M | 691.94M | 575.06M | 571.57M | 478.21M | 384.60M | 275.67M | 206.54M | 345.18M | 341.58M | 342.08M |
| EBITDA Ratio | 15.20% | 20.20% | 17.23% | 20.88% | 20.72% | 23.38% | 21.34% | 21.12% | 17.32% | 14.81% | 11.59% | 6.51% | 15.72% | 15.66% | 12.88% |
| Operating Income | 312.66M | 535.11M | 515.86M | 467.64M | 430.94M | 418.50M | 418.09M | 409.82M | 309.30M | 164.96M | 99.29M | 47.94M | 230.07M | 229.37M | 226.17M |
| Operating Income Ratio | 9.17% | 14.81% | 12.60% | 14.94% | 14.83% | 13.94% | 15.16% | 14.87% | 11.20% | 6.35% | 4.12% | 2.09% | 10.01% | 10.65% | 11.42% |
| Total Other Income/Expenses | 16.46M | -4.52M | -19.26M | -11.50M | -3.31M | 113.09M | 8.39M | 5.00M | 10.04M | 80.80M | 40.84M | 34.93M | 15.43M | -5.14M | 57.45M |
| Income Before Tax | 329.12M | 530.59M | 509.92M | 464.04M | 428.55M | 531.59M | 426.48M | 414.82M | 319.34M | 245.76M | 143.54M | 78.21M | 232.64M | 224.23M | 283.61M |
| Income Before Tax Ratio | 9.65% | 14.68% | 12.45% | 14.82% | 14.74% | 17.71% | 15.47% | 15.06% | 11.57% | 9.46% | 5.96% | 3.41% | 10.12% | 10.42% | 14.32% |
| Income Tax Expense | 111.82M | 103.07M | 97.76M | 89.45M | 83.04M | 78.85M | 72.78M | 62.85M | 50.41M | 31.29M | 17.58M | 104.00K | 38.57M | 42.82M | 73.85M |
| Net Income | 300.39M | 426.70M | 393.23M | 365.09M | 345.50M | 452.74M | 353.69M | 351.97M | 268.93M | 214.47M | 125.95M | 78.11M | 194.07M | 181.41M | 209.77M |
| Net Income Ratio | 8.81% | 11.81% | 9.60% | 11.66% | 11.89% | 15.08% | 12.83% | 12.77% | 9.74% | 8.26% | 5.23% | 3.40% | 8.44% | 8.43% | 10.59% |
| EPS | 1.50 | 2.13 | 1.97 | 1.83 | 1.73 | 2.26 | 1.77 | 1.76 | 1.34 | 1.07 | 0.46 | 0.29 | 0.97 | 0.90 | 1.04 |
| EPS Diluted | 1.50 | 2.13 | 1.96 | 1.82 | 1.72 | 2.26 | 1.76 | 1.75 | 1.34 | 1.07 | 0.46 | 0.28 | 0.97 | 0.90 | 1.04 |
| Weighted Avg Shares Out | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 275.96M | 278.10M | 199.95M | 199.95M | 199.95M |
| Weighted Avg Shares Out (Dil) | 200.48M | 200.64M | 200.57M | 200.55M | 200.52M | 200.70M | 200.48M | 200.56M | 200.42M | 200.23M | 276.11M | 278.36M | 200.19M | 200.21M | 200.15M |
Source: https://incomestatements.info
Category: Stock Reports